Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

30 results about "Normal female" patented technology

CGH array quality assessment

Methods, systems and computer readable media for characterizing quality of CGH arrays, including generating at least one metric for a CGH array that characterizes a property of the CGH array; repeating generation of the at least one metric for at least one additional CGH array; and comparing each metric across all CGH array metric values generated to identify a quality of any one of the CGH arrays characterized, relative to the CGH arrays characterized for that metric. Methods, systems and computer readable media for determining the quality of a CGH array, including calculating a spread of the derivative of log ratio value differences between consecutive probes representing consecutive positions along a chromosome, wherein ratio values are calculated from probe signals from a CGH array, as read by a reader on first and second channels thereof, or from probes signals from two CGH arrays, as read by a single channel reader. Methods, systems and computer readable media for qualifying a CGH array, including quantifying an interarray reproducibility metric characterizing selected sets of probe replicates. Methods, systems and computer readable media for qualifying a CGH array, including generating a Receiver Operating Characteristic (ROC) curve and analyzing false positive and true positive signals from a normal male sample and a normal female sample, as read by a reader on first and second channels thereof, or from one of a normal male sample and a normal female sample on the CGH array and the other of the normal male sample and normal female sample on a second CGH array, as read by a single-channel reader. Methods, systems and computer readable media for determining the quality of a CGH array, including segmenting, by copy number, log ratio signals from probes on the CGH array representing a genome; plotting a probability distribution of the segmented log ratio values; and quantifying separation between copy number peaks resulting from the plotting of the probability distribution.
Owner:AGILENT TECH INC

Quality control plasma for noninvasive prenatal detection and preparation method thereof

ActiveCN111440860AAlleviate the downside of difficult accessMicrobiological testing/measurementGynecologyNormal female
The invention relates to quality control plasma for noninvasive prenatal detection and a preparation method thereof. The quality control plasma comprises positive quality control plasma, negative quality control plasma and detection limit-type quality control plasma; the positive quality control plasma comprises a mixed solution which is composed of a positive quality control product of a verifiedkit and stored pregnant woman plasma with a low-risk non-invasive prenatal detection result and a normal female fetus after birth; the negative quality control plasma comprises a stored pregnant woman plasma solution with a negative non-invasive prenatal detection result and a normal female fetus after birth; and the detection limit-type quality control plasma comprises a mixed solution of plasmaof a healthy non-pregnant woman and the positive quality control product of the verified kit. The method has the advantages that: a mixed solution of negative specimen plasma of the pregnant woman and the positive quality control product of the verified kit is used for replacing existing positive specimen plasma, and due to the fact that negative specimen plasma is more, the defect that the positive specimen plasma is difficult to obtain can be greatly relieved.
Owner:SHAOXING WOMEN & CHILDRENS HOSPITAL +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products